Nasus Pharma NSRX
NYSE NSRX
$3.61 +0.02 (+0.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nasus Pharma (NSRX) Non-Current Assets (2024 - 2026)

Updated

Nasus Pharma's Non-Current Assets came in at $138,000 for Q2 2026, down 60.3% from $348,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Non-Current Assets was $149,000, down 42.7% from FY2024.

  • Going back by year, Non-Current Assets was $260,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Nasus Pharma 32.00 Mn 32.00 Mn - 138,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138,000.00
Dec 31, 2025 149,000.00
Jun 30, 2025 348,000.00
Dec 31, 2024 260,000.00
API Access

Nasus Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY